#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14516	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2232	647.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1601	1601	C	867	C,A	810,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25938	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3566	725.7	0	.	n	.	0	A20C	SNP	20	20	A	384	384	C	423	C,A	399,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25938	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3566	725.7	0	.	n	.	0	T695C	SNP	695	695	T	1059	1059	C	866	C	832	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25938	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3566	725.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2002	2002	G	849	G,A	805,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25938	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3566	725.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2335	2335	C	880	C	817	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25938	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3566	725.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2409	2409	A	876	A	827	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25938	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3566	725.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2961	2961	C	825	C,A	779,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2146	folP	855	855	100.0	folP.l15.c4.ctg.1	1597	133.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1014	1016	AGC	217;211;211	A;G;C	203;199;200	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5830	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3413	170.5	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	189;187;187	T;T;C	176;174;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5830	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3413	170.5	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	188;187;185	G;G;C	173;167;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5830	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3413	170.5	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	188;187;185	G;G;C	173;167;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1676	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1330	125.8	0	.	p	.	0	F184L	NONSYN	550	552	TTC	881	883	TTG	214;215;214	T;T;G	198;202;200	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1676	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1330	125.8	1	SNP	p	G45D	0	.	.	133	135	GGC	464	466	GGC	212;211;209	G;G;C,T	199;195;193,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	888	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1011	87.5	0	.	n	.	0	A197.	DEL	197	197	A	550	550	A	202	A	192	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5344	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2927	181.9	1	SNP	p	D86N	0	.	.	256	258	GAC	509	511	GAC	208;208;213	G;A,G;C	200;197,1;204	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5344	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2927	181.9	1	SNP	p	S87R	1	.	.	259	261	CGT	512	514	CGT	214;213;214	C,A;G;T	201,2;200;200	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5344	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2927	181.9	1	SNP	p	R87I	0	.	.	259	261	CGT	512	514	CGT	214;213;214	C,A;G;T	201,2;200;200	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5344	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2927	181.9	1	SNP	p	R87W	0	.	.	259	261	CGT	512	514	CGT	214;213;214	C,A;G;T	201,2;200;200	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5344	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2927	181.9	1	SNP	p	S88P	0	.	.	262	264	TCC	515	517	TCC	215;213;215	T;C;C	204;201;205	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4370	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2720	160.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1552	1554	GGC	191;191;187	G;G;C	176;173;171	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1226	1228	GCA	241;241;244	G;C;A	220;221;223	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1229	1231	ATC	249;247;249	A;T;C	226;227;229	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1241	1243	GTG	249;252;253	G;T,C;G	229;230,1;231	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1241	1243	GTG	249;252;253	G;T,C;G	229;230,1;231	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1745	1747	ACC	233;232;232	A;C;C	213;211;213	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1799	1801	GCG	222;222;223	G;C;G	200;181;189	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1799	1801	GCG	222;222;223	G;C;G	200;181;189	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1922	1924	AGC	191;187;184	A;G;C	182;178;174	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1931	1933	GGC	175;176;177	G;G;C	166;169;165	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4084	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2317	175.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1949	1951	CCG	157;159;162	C,G;C;G	118,4;123;122	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5430	ponA	2397	2397	99.92	ponA.l6.c30.ctg.1	3258	166.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2492	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1809	137.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	175	C	154	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	112	91.96	porB1a.l6.c30.ctg.1	521	38.2	0	.	p	.	0	M18T	NONSYN	52	54	ATG	372	374	ACG	94;94;91	A;C;G	84;84;79	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	112	91.96	porB1a.l6.c30.ctg.1	521	38.2	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	414	416	CAA	50;50;46	C;A;A	47;47;43	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	112	91.96	porB1a.l6.c30.ctg.1	521	38.2	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	420	422	TAC	35;35;30	T;A;C	34;33;30	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	376	378	GAA	242;240;240	G;A;A	229;230;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	787	789	TCA	212;212;214	T;C;A	200;200;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	916	918	GTC	203;204;204	G;T,C;C	191;189,1;193	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	928	930	TCT	199;200;200	T;C;T	193;192;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1246	1248	GCA	235;234;234	G;C;A	225;225;224	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	1	SNP	p	G120K	1	.	.	358	360	AAG	622	624	AAG	207;210;207	A;A;G	196;196;194	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	1	SNP	p	A121D	1	.	.	361	363	GAC	625	627	GAC	201;198;202	G;A;C	185;185;191	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2782	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1556	177.6	1	SNP	p	D121N	0	.	.	361	363	GAC	625	627	GAC	201;198;202	G;A;C	185;185;191	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9814	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4898	200.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1060	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1077	97.9	1	SNP	p	V57M	1	.	.	169	171	ATG	622	624	ATG	233;235;229	A;T;G	220;222;216	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
